These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13180)

  • 21. The granulation of ternary mixtures: the effect of the solubility of the excipients.
    Jaiyeoba KT; Spring MS
    J Pharm Pharmacol; 1980 Jan; 32(1):1-5. PubMed ID: 6102118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of multifunctional magnesium aluminosilicate materials as novel family of glidants in solid dosage products.
    Tran DT; Komínová P; Kulaviak L; Zámostný P
    Int J Pharm; 2021 Jan; 592():120054. PubMed ID: 33176198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The distribution of components in the different size fractions of granules prepared from binary mixtures.
    Opakunle WO; Spring MS
    J Pharm Pharmacol; 1977 May; 29(5):298-302. PubMed ID: 17695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
    Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
    Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of temperature on the tensile strength and disintegration of paracetamol and oxytetracycline tablets.
    Pilpel N; Esezobo S
    J Pharm Pharmacol; 1977 Jul; 29(7):389-92. PubMed ID: 19574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations.
    Guchardi R; Frei M; John E; Kaerger JS
    Int J Pharm; 2008 Feb; 348(1-2):10-7. PubMed ID: 17689898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of powder failure testing equipment in assessing effect on glidants on flowability of cohesive pharmaceutical powders.
    York P
    J Pharm Sci; 1975 Jul; 64(7):1216-21. PubMed ID: 1151687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of physico-chemical and bulk characteristics of co-spray dried L-leucine and polyvinylpyrrolidone on glidant and binder properties in interactive mixtures.
    Mangal S; Meiser F; Lakio S; Morton D; Larson I
    Int J Pharm; 2015 Feb; 479(2):338-48. PubMed ID: 25572691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of porosity and pore-size distribution of aspirin tablets relevant to drug stability.
    Gucluyildiz H; Banker GS; Peck GE
    J Pharm Sci; 1977 Mar; 66(3):407-14. PubMed ID: 191587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of powder flow properties on capsule filling weight uniformity.
    Osorio JG; Muzzio FJ
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1464-75. PubMed ID: 23902366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating.
    Zhou Q; Armstrong B; Larson I; Stewart PJ; Morton DA
    J Pharm Sci; 2010 Feb; 99(2):969-81. PubMed ID: 19795479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Material Properties on the Effectiveness of Glidants Used to Improve the Flowability of Cohesive Pharmaceutical Powders.
    Sunkara D; Capece M
    AAPS PharmSciTech; 2018 May; 19(4):1920-1930. PubMed ID: 29663287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of directly compressible powders via co-spray drying.
    Gonnissen Y; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2007 Aug; 67(1):220-6. PubMed ID: 17317123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The granulation of ternary mixtures containing lactose and boric acid with different starches.
    Jaiyeoba KT; Spring MS
    J Pharm Pharmacol; 1979 Apr; 31(4):197-200. PubMed ID: 36454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cohesion of particulate solids. II. Influence of particle size].
    Fukuzawa H; Kimura S
    Yakugaku Zasshi; 1972 Nov; 92(11):1415-22. PubMed ID: 4346699
    [No Abstract]   [Full Text] [Related]  

  • 37. Incorporation of acetaminophen as an active pharmaceutical ingredient into porous lactose.
    Ebrahimi A; Saffari M; Dehghani F; Langrish T
    Int J Pharm; 2016 Feb; 499(1-2):217-227. PubMed ID: 26768724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Powder compression mechanics of spray-dried lactose nanocomposites.
    Hellrup J; Nordström J; Mahlin D
    Int J Pharm; 2017 Feb; 518(1-2):1-10. PubMed ID: 28007544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precipitated silica as flow regulator.
    Müller AK; Ruppel J; Drexel CP; Zimmermann I
    Eur J Pharm Sci; 2008 Aug; 34(4-5):303-8. PubMed ID: 18595668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of ointment formulations prepared with Achyrocline satureioides spray-dried extracts.
    De Paula IC; Ortega GG; Bassani VL; Petrovick PR
    Drug Dev Ind Pharm; 1998 Mar; 24(3):235-41. PubMed ID: 9876580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.